This study was followed by a second randomized , double-blind parallel-group trial in healthy adult men ( n = @ ) also treated with @ mg oral rilapladib or placebo once daily for @ days using a full range of @ collagen concentrations ( @-@ g/ml ) for characterizing EC@ values for platelet aggregation for each subject .